123 related articles for article (PubMed ID: 33400617)
21. Effects of dacomitinib on the pharmacokinetics of poziotinib
Ji W; Shen J; Wang B; Chen F; Meng D; Wang S; Dai D; Zhou Y; Wang C; Zhou Q
Pharm Biol; 2021 Dec; 59(1):457-464. PubMed ID: 33899675
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of silybin on pharmacokinetics of imatinib in vivo and in vitro.
Wang L; Wang Z; Xia MM; Wang YY; Wang HY; Hu GX
Can J Physiol Pharmacol; 2014 Nov; 92(11):961-4. PubMed ID: 25365188
[TBL] [Abstract][Full Text] [Related]
23. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor.
Zhang L; Mao Y; Gao Z; Chen X; Li X; Liu Y; Xia G
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):15-26. PubMed ID: 31494843
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Baohuoside I on the Metabolism of Tofacitinib in Rats.
Shi Y; Lu Z; Song W; Wang Y; Zhou Q; Geng P; Zhou Y; Wang S; Han A
Drug Des Devel Ther; 2024; 18():931-939. PubMed ID: 38560524
[TBL] [Abstract][Full Text] [Related]
25. Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinib.
Zayed A; Al Hroot J; Mayyas A; Al-Husein B
Fundam Clin Pharmacol; 2023 Oct; 37(5):983-993. PubMed ID: 37143385
[TBL] [Abstract][Full Text] [Related]
26. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
27. Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite.
Liu S; Hou L; Li C; Zhao Y; Yao X; Zhang X; Tian X
Front Pharmacol; 2021; 12():761814. PubMed ID: 34721047
[TBL] [Abstract][Full Text] [Related]
28. Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: a possible role of cytochrome P3A4 inhibition.
Zhang XF; Liu J; Ye F; Ji SG; Zhang N; Cao RS; He L; Wu JC; Li XF
Chin J Integr Med; 2014 Jul; 20(7):534-9. PubMed ID: 24420925
[TBL] [Abstract][Full Text] [Related]
29. Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.
Yu C; Shin YG; Kosmeder JW; Pezzuto JM; van Breemen RB
Rapid Commun Mass Spectrom; 2003; 17(4):307-13. PubMed ID: 12569440
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Axitinib on Buspirone Metabolism in vitro and in vivo.
Zhang BW; Pang NH; Xu RA; Qu GE; Tang CR
Drug Des Devel Ther; 2022; 16():2031-2042. PubMed ID: 35795848
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.
Kumar V; Schuck EL; Pelletier RD; Farah N; Condon KB; Ye M; Rowbottom C; King BM; Zhang ZY; Saxton PL; Wong YN
Cancer Chemother Pharmacol; 2012 Jan; 69(1):229-37. PubMed ID: 21698359
[TBL] [Abstract][Full Text] [Related]
34. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo.
He J; Fang P; Zheng X; Wang C; Liu T; Zhang B; Wen J; Xu RA
Drug Des Devel Ther; 2018; 12():513-519. PubMed ID: 29563776
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
[TBL] [Abstract][Full Text] [Related]
37. Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Xenobiotica; 2001 Oct; 31(10):713-23. PubMed ID: 11695850
[TBL] [Abstract][Full Text] [Related]
38.
Yang L; Wang Y; Xu H; Huang G; Zhang Z; Ma Z; Gao Y
Evid Based Complement Alternat Med; 2019; 2019():3508658. PubMed ID: 31057647
[TBL] [Abstract][Full Text] [Related]
39. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
40. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
